Pervistop[R], the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide.
By asianet
– Lo.Li. Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners. Pervistop[R] promises to be an extremely effective tool in the management of an exceedingly unpredictable disease. Lo.Li. Pharma International announces the pre-launch of a new, highly anticipated product at CPHI 2022, fulfilling … Continued